Inventor · disambiguated record
Patrick Miossec
Also filed as: MIOSSEC PATRICK
4 granted patents·20 pending applications·23 citations·filing 2008–2024
73Inventor score
Files withSANOFI AVENTIS DEUTSCHLAND16BOKA GABOR2SILVESTRE LOUISE2AUTIER VALERIE1NIEMOELLER ELISABETH1
Top patents by PatentIndex Score
24 records- 0183US8735349B2Method for improving glucose tolerance in a diabetes type 2 patient of younger than 50 years and having postprandial plasma glucose concentration of at least 14 mmol/LSILVESTRE LOUISE·Filed 2012·Granted May 27, 2014·18 cites·9 claims
- 0282US2025134964A1Method for inducing weight loss in a type 2 diabetes mellitus patientSANOFI AVENTIS DEUTSCHLAND·Filed 2024·Application pending·0 cites
- 0378US9981013B2Use of AVE0010 for the treatment of diabetes mellitus type 2SANOFI AVENTIS DEUTSCHLAND·Filed 2016·Granted May 29, 2018·2 cites·8 claims
- 0472US2022347269A1Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulinSANOFI AVENTIS DEUTSCHLAND·Filed 2022·Application pending·0 cites
- 0571US2023028588A1Pharmaceutical combination for use in glycemic control in diabetes type 2 patientsSANOFI AVENTIS DEUTSCHLAND·Filed 2022·Application pending·0 cites
- 0671US2020338171A1Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulinSANOFI AVENTIS DEUTSCHLAND·Filed 2019·Application pending·0 cites
- 0771US2022054594A1Use of ave0010 for the manufacture of a medicament for the treatment of diabetes mellitus type 2SANOFI AVENTIS DEUTSCHLAND·Filed 2021·Application pending·0 cites
- 0869US2020353054A1Use of ave0010 for the treatment of diabetes mellitus type 2SANOFI AVENTIS DEUTSCHLAND·Filed 2019·Application pending·0 cites
- 0967US9821032B2Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulinNIEMOELLER ELISABETH·Filed 2012·Granted Nov 21, 2017·2 cites·14 claims
- 1060US9408893B2Pharmaceutical combination for use in glycemic control in diabetes type 2 patientsNIEMÖELLER ELISABETH·Filed 2012·Granted Aug 9, 2016·1 cites·2 claims
- 1160US2020330559A1Pharmaceutical combination for use in glycemic control in diabetes type 2 patientsSANOFI AVENTIS DEUTSCHLAND·Filed 2020·Application pending·0 cites
- 1258US2019030132A1Use of AVE0010 for the Treatment of Diabetes Mellitus Type 2SANOFI AVENTIS DEUTSCHLAND·Filed 2018·Application pending·0 cites
- 1357US2018339023A1Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulinSANOFI AVENTIS DEUTSCHLAND·Filed 2018·Application pending·0 cites
- 1455US2019134160A1Pharmaceutical Combination for Use in Glycemic Control in Diabetes Type 2 PatientsSANOFI AVENTIS DEUTSCHLAND·Filed 2018·Application pending·0 cites
- 1553US2019054146A1Prevention of hypoglycemia in diabetes mellitus type 2 patientsSANOFI AVENTIS DEUTSCHLAND·Filed 2018·Application pending·0 cites
- 1651US2017143801A1Pharmaceutical Combination for Use in Glycemic Control in Diabetes Type 2 PatientsSANOFI AVENTIS DEUTSCHLAND·Filed 2017·Application pending·0 cites
- 1748US2014148384A1Use of ave0010 for the manufacture of a medicament for the treatment of diabetes mellitus type 2BOKA GABOR·Filed 2010·Application pending·0 cites
- 1846US2017080057A1Prevention of hypoglycemia in diabetes mellitus type 2 patientsSANOFI AVENTIS DEUTSCHLAND·Filed 2016·Application pending·0 cites
- 1945US2013085102A1Prevention of hypoglycemia in diabetes mellitus type 2 patientsSILVESTRE LOUISE·Filed 2012·Application pending·0 cites
- 2043US2010273872A1Use of 4-oxobutanoic acid derivatives in the treatment of pathologies associated with immunological disordersAUTIER VALERIE·Filed 2008·Application pending·0 cites
- 2143US2018000902A1Prevention of hypoglycaemia in diabetes mellitus type 2 patientsSANOFI AVENTIS DEUTSCHLAND·Filed 2017·Application pending·0 cites
- 2242US2012277147A1Prevention of hypoglycaemia in diabetes mellitus type 2 patientsBOKA GABOR·Filed 2012·Application pending·0 cites
- 2337US2013040878A1Pharmaceutical combination for use in the treatment of diabetes type 2 patientsSANOFI AVENTIS DEUTSCHLAND·Filed 2012·Application pending·0 cites
- 2436US2013065828A1Pharmaceutical combination for use in glycemic control in diabetes type 2 patientsRUUS PETER·Filed 2012·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Patrick Miossec files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →